Prevalence and Impact of Lupus Anticoagulant in Patients Receiving Extracorporeal Membrane Oxygenation
Andrea Kornfehl(Medical University of Vienna), Nina Buchtele(Medical University of Vienna), Michael Schwameis(Medical University of Vienna), Roman Brock(Medical University of Vienna), Oliver Robak(Medical University of Vienna), Alexander Hermann(Universitätszahnklinik Wien), Thomas Staudinger(Northwestern University), Peter Schellongowski(Medical University of Vienna), Bernhard Nagler(Medical University of Vienna), Peter Quehenberger
Cited by 3
Related Papers
Attributable mortality of ventilator-associated pneumonia: a meta-analysis of individual patient data from randomised prevention studies
|The Lancet Infectious Diseases|2013|876
Lower tidal volume strategy (≈3 ml/kg) combined with extracorporeal CO2 removal versus ‘conventional’ protective ventilation (6 ml/kg) in severe ARDS
|Intensive Care Medicine|2013|603
Symptoms of burnout in intensive care unit specialists facing the COVID-19 outbreak
|Annals of Intensive Care|2020|392
Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unit
|Critical Care Medicine|2000|344
Tissue factor-positive microparticles: Cellular origin and association with coagulation activation in patients with colorectal cancer
|Thrombosis and Haemostasis|2007|285